Zhejiang Jiuzhou Pharm Co Ltd Tangible Net Worth Ratio

Latest as of June 2026: 94.5%

Zhejiang Jiuzhou Pharm Co Ltd tangible net worth ratio. Zhejiang Jiuzhou Pharm Co Ltd (603456) has a Tangible Net Worth Ratio of 94.5% as of June 2026. This metric is calculated by deducting intangible assets (CN¥494.98 Million) from net assets (CN¥8.96 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 603456 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Tangible NW Ratio

94.5%
Tangible equity / total equity

Net Assets (Equity)

CN¥8.96 Billion
CNY

Intangible Assets

CN¥494.98 Million
Goodwill, patents, brand value

Total Assets

CN¥10.64 Billion
CNY

Tangible Net Worth Ratio of Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)

Tangible net worth ratio of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025. This chart shows how Zhejiang Jiuzhou Pharm Co Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 94.5%, reflecting net assets of CN¥8.96 Billion with intangible assets of CN¥494.98 Million CNY. See Zhejiang Jiuzhou Pharm Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Jiuzhou Pharm Co Ltd Tangible Net Worth Ratio by Year (2008–2025)

Zhejiang Jiuzhou Pharm Co Ltd tangible net worth ratio by year from 2008 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 603456 market cap overview.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 94.2% CN¥8.79 Billion CN¥509.32 Million CN¥10.60 Billion ▲ +0.9 pp
2024 93.3% CN¥8.61 Billion CN¥572.93 Million CN¥11.13 Billion ▲ +0.0 pp
2023 93.3% CN¥8.53 Billion CN¥571.94 Million CN¥10.85 Billion ▲ +2.9 pp
2022 90.4% CN¥5.37 Billion CN¥517.02 Million CN¥7.91 Billion ▼ -0.3 pp
2021 90.7% CN¥4.58 Billion CN¥427.61 Million CN¥7.04 Billion ▼ -1.7 pp
2020 92.4% CN¥3.09 Billion CN¥235.78 Million CN¥5.00 Billion ▲ +2.0 pp
2019 90.3% CN¥2.86 Billion CN¥276.46 Million CN¥4.67 Billion ▼ -2.5 pp
2018 92.8% CN¥2.78 Billion CN¥200.23 Million CN¥3.30 Billion ▲ +0.5 pp
2017 92.3% CN¥2.68 Billion CN¥207.55 Million CN¥3.14 Billion ▼ -1.7 pp
2016 94.0% CN¥2.57 Billion CN¥154.23 Million CN¥3.00 Billion ▼ -1.2 pp
2015 95.2% CN¥2.52 Billion CN¥121.98 Million CN¥3.34 Billion ▼ -1.4 pp
2014 96.5% CN¥1.58 Billion CN¥55.19 Million CN¥2.21 Billion ▲ +5.8 pp
2013 90.8% CN¥736.75 Million CN¥68.05 Million CN¥1.55 Billion ▲ +2.5 pp
2012 88.3% CN¥597.08 Million CN¥69.85 Million CN¥1.34 Billion ▲ +3.8 pp
2011 84.5% CN¥460.54 Million CN¥71.21 Million CN¥1.11 Billion ▲ +1.6 pp
2010 83.0% CN¥343.94 Million CN¥58.55 Million CN¥855.97 Million ▲ +6.5 pp
2009 76.4% CN¥245.87 Million CN¥57.91 Million CN¥634.32 Million ▲ +4.7 pp
2008 71.7% CN¥175.41 Million CN¥49.62 Million CN¥586.69 Million —
pp = percentage points